As I mentioned in a previous post, diagnostic uncertainty drives antibiotic use, so getting answers to clinicians faster is an important piece of the antimicrobial stewardship pie. NIH is stepping up and funding several efforts around the country. From the press release:
“The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria.”
The funded researchers include a mix of companies and academic centers including BioFire Diagnostics, LLC and Brigham Young University in Provo, Utah.
Read the full press release here.
–Kelly Swails, MT(ASCP), is a laboratory professional, recovering microbiologist, and web editor for Lab Medicine.